Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
28.84
-0.38 (-1.30%)
At close: Sep 4, 2025, 4:00 PM
29.21
+0.37 (1.28%)
Pre-market: Sep 5, 2025, 7:42 AM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $2.48 billion as of September 5, 2025. Its market cap has increased by 129.14% in one year.
Market Cap
2.48B
Enterprise Value
2.51B
1-Year Change
129.14%
Ranking
Category
Stock Price
$28.84
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $2.48B, an increase of 1,379.89%. That is a compound annual growth rate of 46.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 2.52B | 152.74% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | 127.84M | 60.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |